JP2004121246A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004121246A5 JP2004121246A5 JP2003319474A JP2003319474A JP2004121246A5 JP 2004121246 A5 JP2004121246 A5 JP 2004121246A5 JP 2003319474 A JP2003319474 A JP 2003319474A JP 2003319474 A JP2003319474 A JP 2003319474A JP 2004121246 A5 JP2004121246 A5 JP 2004121246A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- same
- salt
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 35
- 108090000623 proteins and genes Proteins 0.000 claims 29
- 150000003839 salts Chemical class 0.000 claims 25
- 102000004169 proteins and genes Human genes 0.000 claims 24
- 108090000765 processed proteins & peptides Proteins 0.000 claims 20
- 239000003814 drug Substances 0.000 claims 14
- 150000001875 compounds Chemical class 0.000 claims 12
- 239000002157 polynucleotide Substances 0.000 claims 9
- 102000040430 polynucleotide Human genes 0.000 claims 9
- 108091033319 polynucleotide Proteins 0.000 claims 9
- 238000012216 screening Methods 0.000 claims 8
- 229940124597 therapeutic agent Drugs 0.000 claims 8
- 206010012601 diabetes mellitus Diseases 0.000 claims 6
- 230000004770 neurodegeneration Effects 0.000 claims 6
- 208000015122 neurodegenerative disease Diseases 0.000 claims 6
- 206010028980 Neoplasm Diseases 0.000 claims 5
- 201000011510 cancer Diseases 0.000 claims 5
- 239000000032 diagnostic agent Substances 0.000 claims 5
- 229940039227 diagnostic agent Drugs 0.000 claims 5
- 230000000694 effects Effects 0.000 claims 5
- 230000003449 preventive effect Effects 0.000 claims 5
- 208000025747 Rheumatic disease Diseases 0.000 claims 4
- 230000000069 prophylactic effect Effects 0.000 claims 3
- 230000000692 anti-sense effect Effects 0.000 claims 2
- 230000000295 complement effect Effects 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 239000002773 nucleotide Substances 0.000 claims 2
- 125000003729 nucleotide group Chemical group 0.000 claims 2
- 208000019802 Sexually transmitted disease Diseases 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003319474A JP2004121246A (ja) | 2002-09-13 | 2003-09-11 | 神経変性疾患の予防・治療剤 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002269091 | 2002-09-13 | ||
| JP2003319474A JP2004121246A (ja) | 2002-09-13 | 2003-09-11 | 神経変性疾患の予防・治療剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004121246A JP2004121246A (ja) | 2004-04-22 |
| JP2004121246A5 true JP2004121246A5 (enExample) | 2006-10-26 |
Family
ID=32301633
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003319474A Pending JP2004121246A (ja) | 2002-09-13 | 2003-09-11 | 神経変性疾患の予防・治療剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2004121246A (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119656157B (zh) * | 2025-01-13 | 2025-06-10 | 安徽农业大学 | 4μ8C在制备防治家蚕核型多角体病毒制剂中的应用 |
-
2003
- 2003-09-11 JP JP2003319474A patent/JP2004121246A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2925098T3 (es) | Activador triple que activa el receptor de glucagón, GLP-1 Y GIP | |
| WO2020150552A2 (en) | Methods of treating cartilage disorders through inhibition of clk and dyrk | |
| CA2529179A1 (en) | Recombinant adeno-associated virus vector for treatment of alzheimer disease | |
| ATE364698T1 (de) | Neues, physiologisch aktives peptid und dessen verwendung | |
| JP2005508311A (ja) | ｏ−フェニレンジアミンのＮ−モノアシル化誘導体、その六員複素環式アナログ、及び薬剤としてのそれらの使用 | |
| JP2009514954A (ja) | Ｔｒｐｖ３機能を変調するための化合物 | |
| KR20060054174A (ko) | 항-아밀로이드 항체, 조성물, 방법 및 용도 | |
| GB0211649D0 (en) | Organic compounds | |
| BR0309553A (pt) | Composto ou sal farmaceuticamente aceitável ou éster ou amida hidrolisável in vivo deste, processo para prepará-lo, composição farmacêutica, uso do composto, e, métodos para produzir um efeito inibidor de hdac em um animal de sangue quente, e para tratar câncer em um animal de sangue quente | |
| EA201201114A1 (ru) | Агонистические dr5-связывающие полипептиды | |
| UA107578C2 (uk) | Комбінована терапія при лікуванні діабету | |
| WO2005040418A3 (en) | Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (r-spondins) and/or wnt | |
| JPWO2011126054A1 (ja) | 生理活性ペプチド | |
| TW200732351A (en) | New cyclic peptide compounds | |
| RU2006131553A (ru) | Комбинация(а) ингибитора топоизомеразы днк и (б) ингибитора iap | |
| JP2006158399A5 (ja) | 細胞増殖抑制タンパク質並びにそれを用いる細胞増殖抑制剤、癌診断薬及び癌治療剤 | |
| JP2004121246A5 (enExample) | ||
| JP2010533660A5 (enExample) | ||
| WO2003014703A3 (en) | Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof | |
| JP2008522632A5 (enExample) | ||
| WO2002062944A2 (en) | Novel physiologically active peptide and use thereof | |
| JP2002355060A5 (enExample) | ||
| JP2007517775A5 (enExample) | ||
| JP2004073182A5 (enExample) | ||
| BR0315917A (pt) | Utilização do sal distrÈnico do ácido 2-[n,n-di(carboximetil)amino]-3-ciano-4-carboximetil-ti ofeno-5-carboxìlico para a obtenção de medicamentos destinados ao tratamento das dores gastroduodenais |